JP2020529472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529472A5 JP2020529472A5 JP2020527859A JP2020527859A JP2020529472A5 JP 2020529472 A5 JP2020529472 A5 JP 2020529472A5 JP 2020527859 A JP2020527859 A JP 2020527859A JP 2020527859 A JP2020527859 A JP 2020527859A JP 2020529472 A5 JP2020529472 A5 JP 2020529472A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- compound
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*CC1OC1N(*)C(C)* Chemical compound C*CC1OC1N(*)C(C)* 0.000 description 6
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762538477P | 2017-07-28 | 2017-07-28 | |
| US62/538,477 | 2017-07-28 | ||
| PCT/US2018/044182 WO2019023634A1 (en) | 2017-07-28 | 2018-07-27 | CYCLATIVE RELEASE OF PEPTIDE COMPOUNDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529472A JP2020529472A (ja) | 2020-10-08 |
| JP2020529472A5 true JP2020529472A5 (https=) | 2021-09-09 |
Family
ID=63312461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527859A Pending JP2020529472A (ja) | 2017-07-28 | 2018-07-27 | ペプチド化合物の環化放出関連する出願の相互参照 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11299513B2 (https=) |
| EP (1) | EP3658567A1 (https=) |
| JP (1) | JP2020529472A (https=) |
| WO (1) | WO2019023634A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112592382B (zh) * | 2020-11-27 | 2022-10-04 | 安徽大学 | 一种树脂及其制备方法以及其在制备头尾环肽中的应用 |
| CN120309693B (zh) * | 2025-06-12 | 2025-09-16 | 杭州湃肽生化科技有限公司 | 一类环肽化合物及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP616598A0 (en) * | 1998-09-25 | 1998-10-15 | University Of Queensland, The | Auxiliary for amide bond formation |
| GB9928323D0 (en) | 1999-11-30 | 2000-01-26 | Cyclacel Ltd | Peptides |
| GB2369823B (en) | 1999-11-30 | 2003-06-04 | Cyclacel Ltd | Assays for cyclin-interacting compounds |
| US20050153894A1 (en) | 1999-11-30 | 2005-07-14 | Cyclacel Limited | p21 peptides |
| EP1345957A2 (en) | 2000-12-20 | 2003-09-24 | Novartis AG | Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| US20040077549A1 (en) | 2000-12-20 | 2004-04-22 | Bair Kenneth Walter | Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| US20040053849A1 (en) | 2000-12-20 | 2004-03-18 | Bair Kenneth Walter | Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| JP2004269357A (ja) | 2002-01-25 | 2004-09-30 | Marine Biotechnol Inst Co Ltd | 鉄と高い結合能を有する化合物およびその製造方法 |
| WO2006105386A1 (en) | 2005-03-30 | 2006-10-05 | Genentech, Inc. | Cdk2 inhibitors |
| WO2008000870A1 (es) | 2006-06-19 | 2008-01-03 | Fundación De La Comunidad Valenciana, Centro De Investigación Principe Felipe | Compuestos orgánicos que inhiben la actividad catalítica del complejo ciclina a/kinasa 2 dependiente de ciclina mediante su unión a un nuevo sitio farmacofórico en la molécula de ciclina |
| US20100184684A1 (en) | 2009-01-06 | 2010-07-22 | C3 Jian, Inc. | Antibacterial and antifungal peptides |
| US9376465B2 (en) | 2012-03-27 | 2016-06-28 | University Of South Carolina | Cyclin based inhibitors of CDK2 and CDK4 |
| US20140296484A1 (en) | 2013-03-27 | 2014-10-02 | University Of South Carolina | Cyclin Based Inhibitors of CDK2 and CDK4 |
| US10011635B2 (en) | 2013-09-27 | 2018-07-03 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Cyclic peptide conjugates and methods of use |
| US20190224279A1 (en) | 2015-09-17 | 2019-07-25 | Histide Ag | Pharmaceutical association comprising a growth factor receptor agonist conjugated to a bioactive carrier for converting a neoplastic cell into a non-neoplastic cell and uses thereof |
| DK3349778T3 (da) | 2015-09-17 | 2021-11-22 | Histide Ag | Farmaceutisk association af vækstfaktorreceptoragonist og adhæsionsproteininhibitor til omdannelse af en neoplastisk celle til en ikke-neoplastisk celle og anvendelser deraf |
| AU2016323407A1 (en) | 2015-09-17 | 2018-04-19 | Histide Ag | Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof |
| WO2017046226A2 (en) | 2015-09-17 | 2017-03-23 | Histide Ag | Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof. |
| WO2017046229A1 (en) | 2015-09-17 | 2017-03-23 | Histide Ag | Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof |
| SG10201913355RA (en) | 2015-09-17 | 2020-02-27 | Histide Ag | Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof |
-
2018
- 2018-07-27 US US16/633,969 patent/US11299513B2/en active Active
- 2018-07-27 EP EP18759006.2A patent/EP3658567A1/en not_active Withdrawn
- 2018-07-27 WO PCT/US2018/044182 patent/WO2019023634A1/en not_active Ceased
- 2018-07-27 JP JP2020527859A patent/JP2020529472A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7139511B2 (ja) | ペプチド化合物の製造方法、保護基形成用試薬、及び、縮合多環芳香族炭化水素化合物 | |
| ES2830974T3 (es) | Nuevo agente protector de xanteno | |
| JP6350632B2 (ja) | ペプチドの製造方法 | |
| JPH05247039A (ja) | 新規テトラオキソ−ジアザビシクロ−(3,3,1)−ノナンおよびその製法 | |
| JP7238123B2 (ja) | ペプチド化合物の製造方法、保護基形成用試薬、及び、縮合多環芳香族炭化水素化合物 | |
| JP3866279B2 (ja) | ペプチド連結用の新規な試薬 | |
| JP2020529472A5 (https=) | ||
| JP6744293B2 (ja) | オキシトシン類似体の製造方法 | |
| JPWO2018088527A1 (ja) | 新規トリチル保護剤 | |
| JP2021505542A5 (https=) | ||
| JP2011251936A (ja) | ウレイドシラン化合物 | |
| Nair et al. | Formation of a pseudo-β-hairpin motif utilizing the Ant–Pro reverse turn: consequences of stereochemical reordering | |
| JP4079314B2 (ja) | シルセスキオキサン化合物の製造方法 | |
| TW202233574A (zh) | 肽之製造方法、保護基形成用試藥及縮合多環化合物 | |
| KR20010079497A (ko) | 혈관형성 억제제 | |
| JP2020529472A (ja) | ペプチド化合物の環化放出関連する出願の相互参照 | |
| US6265590B1 (en) | Nα-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids | |
| JP5014148B2 (ja) | ペプチドチオエステルの製造方法 | |
| JP6440250B2 (ja) | チオアミド誘導体 | |
| CN103497215B (zh) | 用于免疫佐剂E6020之合成前体的β-酮酰胺合成的试剂和方法 | |
| JP6720913B2 (ja) | 不飽和結合含有ビスシリル化合物およびその製造方法 | |
| JP2002531541A (ja) | カルバメート結合を含むテンプレートとして作用する分子足場 | |
| WO2019200114A1 (en) | Methods for preparing substituted dihydroindene-4-carboxamide compounds | |
| JP2022086691A (ja) | 化合物を製造する方法 | |
| CN103936651A (zh) | 抗丙肝药物Boceprevir的中间体Ⅲ及其制备方法和应用 |